ENROLLMENT IS NOW CLOSED. PLEASE REFER TO OTHER ENROLLING TRIALS.
You are invited to join an online research study and share your opinion while helping the fight against HIV. If you agree to participate, you would be asked to complete three surveys over the course of six months. In addition to the survey, half of the participants will be randomly selected to download a mobile phone application.
Did you know that women account for 50% of the population infected with HIV worldwide?
March 10th, National Women & Girls HIV/AIDS Awareness Day, is a day of particular importance to us at AIDS Research Alliance as we strive to shed more light on the changing face of HIV/AIDS, and the fact that women are increasingly at risk.
In the last year, we have published the stories of two women who are HIV positive
A conversation with new board member, entertainment manager and producer, Barry Krost
“I came out at a very early age – during my early teens. Entertainment was one of the few industries in England where I felt safe and protected. Originally I wanted to be a movie star. I wanted to be loved and adored. But people’s appetite for pear-shaped, short, Jewish gay guys turned out to be limited. One day a friend said to me – ‘Are you willing to be an artist who fails? Or a...
The Food & Drug Administration’s (FDA) approval of botanical drug Fulyzaq (Crofelemer) is of particular significance to AIDS Research Alliance. ARA was an investigational site in the clinical trial stage of the drug’s development, and ARA is working on its own botanically sourced HIV cure strategy – prostratin.
Fulyzaq is the first drug the FDA has ever approved for the treatment of HIV-related diarrhea. Diarrhea is a common side effect of the drugs prescribed...
In February 2013, AIDS Research Alliance (ARA) received a generous bequest of $100,000 from the Susan A. Miller 2010 Trust. ARA was in great company, including the Muscular Dystrophy Association and the American Cancer Society.
Page 7 of 15 pages ‹ First < 5 6 7 8 9 > Last ›